NO20041649L - Et kombinasjonsprodukt omfattende melagatran og dexametason - Google Patents

Et kombinasjonsprodukt omfattende melagatran og dexametason

Info

Publication number: NO20041649L
Authority: NO; Norway
Prior art keywords: melagatran; dexamethasone; combination product; combination; product
Prior art date: 2001-10-26

Application number

NO20041649A

Other languages

English (en)

Inventor

Margreta Elg

Original Assignee

Astrazeneca Ab Global Ip

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-26

Filing date

2004-04-23

Publication date

2004-06-17

2004-04-23 Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip

2004-06-17 Publication of NO20041649L publication Critical patent/NO20041649L/no

Links

239000013066 combination product Substances 0.000 title 1
229940127555 combination product Drugs 0.000 title 1
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 title 1
229960003957 dexamethasone Drugs 0.000 title 1
DKWNMCUOEDMMIN-PKOBYXMFSA-N melagatran Chemical compound C1=CC(C(=N)N)=CC=C1CNC(=O)[C@H]1N(C(=O)[C@H](NCC(O)=O)C2CCCCC2)CC1 DKWNMCUOEDMMIN-PKOBYXMFSA-N 0.000 title 1
229960002137 melagatran Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Neurology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Hematology (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Rheumatology (AREA)
Addiction (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Toxicology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20041649A 2001-10-26 2004-04-23 Et kombinasjonsprodukt omfattende melagatran og dexametason NO20041649L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0103590A SE0103590D0 (sv)	2001-10-26	2001-10-26	New Combination
PCT/SE2002/001938 WO2003035079A1 (en)	2001-10-26	2002-10-24	A combination product comprising melagatran and dexamethasone

Publications (1)

Publication Number	Publication Date
NO20041649L true NO20041649L (no)	2004-06-17

Family

ID=20285798

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20041649A NO20041649L (no)	2001-10-26	2004-04-23	Et kombinasjonsprodukt omfattende melagatran og dexametason

Country Status (15)

Country	Link
US (1)	US7449446B2 (no)
EP (1)	EP1441738A1 (no)
JP (1)	JP2005511544A (no)
KR (1)	KR20040045896A (no)
CN (1)	CN100548303C (no)
AU (1)	AU2002363023B2 (no)
BR (1)	BR0213311A (no)
CA (1)	CA2464085A1 (no)
IL (1)	IL161496A0 (no)
MX (1)	MXPA04003771A (no)
NO (1)	NO20041649L (no)
NZ (1)	NZ532410A (no)
SE (1)	SE0103590D0 (no)
WO (1)	WO2003035079A1 (no)
ZA (1)	ZA200403094B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2020168106A1 (en)	2019-02-13	2020-08-20	Notable Labs, Inc.	Combinations of agonists of protein kinase c with steroids or retinoic acids for the treatment of cancer
US11654057B2 (en)	2020-04-09	2023-05-23	Bio 54, Llc	Devices for bleeding reduction and methods of making and using the same
US11642324B1 (en)	2022-03-01	2023-05-09	Bio 54, Llc	Topical tranexamic acid compositions and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3461208A (en) *	1966-11-01	1969-08-12	Merck & Co Inc	Indomethacin compositions
SE9301916D0 (sv)	1993-06-03	1993-06-03	Ab Astra	New peptides derivatives
SE9404196D0 (sv) *	1994-12-02	1994-12-02	Astra Ab	New antithrombotic formulation
TWI238827B (en)	1995-12-21	2005-09-01	Astrazeneca Ab	Prodrugs of thrombin inhibitors
SE9900070D0 (sv) *	1999-01-13	1999-01-13	Astra Ab	New use
AR023510A1 (es) *	1999-04-21	2002-09-04	Astrazeneca Ab	Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
GB0014134D0 (en)	2000-06-10	2000-08-02	Astrazeneca Ab	Combination therapy
GB0014136D0 (en)	2000-06-10	2000-08-02	Astrazeneca Ab	Combination therapy

2001
- 2001-10-26 SE SE0103590A patent/SE0103590D0/xx unknown
2002
- 2002-10-24 WO PCT/SE2002/001938 patent/WO2003035079A1/en not_active Ceased
- 2002-10-24 CA CA002464085A patent/CA2464085A1/en not_active Abandoned
- 2002-10-24 AU AU2002363023A patent/AU2002363023B2/en not_active Expired - Fee Related
- 2002-10-24 JP JP2003537646A patent/JP2005511544A/ja active Pending
- 2002-10-24 MX MXPA04003771A patent/MXPA04003771A/es not_active Application Discontinuation
- 2002-10-24 CN CNB028212495A patent/CN100548303C/zh not_active Expired - Fee Related
- 2002-10-24 IL IL16149602A patent/IL161496A0/xx unknown
- 2002-10-24 US US10/493,625 patent/US7449446B2/en not_active Expired - Fee Related
- 2002-10-24 BR BR0213311-3A patent/BR0213311A/pt not_active IP Right Cessation
- 2002-10-24 NZ NZ532410A patent/NZ532410A/en not_active IP Right Cessation
- 2002-10-24 EP EP02802081A patent/EP1441738A1/en not_active Withdrawn
- 2002-10-24 KR KR10-2004-7005896A patent/KR20040045896A/ko not_active Ceased
2004
- 2004-04-22 ZA ZA200403094A patent/ZA200403094B/en unknown
- 2004-04-23 NO NO20041649A patent/NO20041649L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN100548303C (zh)	2009-10-14
WO2003035079A1 (en)	2003-05-01
NZ532410A (en)	2006-04-28
AU2002363023B2 (en)	2007-10-25
MXPA04003771A (es)	2005-04-08
US7449446B2 (en)	2008-11-11
CA2464085A1 (en)	2003-05-01
BR0213311A (pt)	2004-10-13
IL161496A0 (en)	2004-09-27
ZA200403094B (en)	2005-01-25
US20050014701A1 (en)	2005-01-20
KR20040045896A (ko)	2004-06-02
JP2005511544A (ja)	2005-04-28
EP1441738A1 (en)	2004-08-04
CN1575179A (zh)	2005-02-02
SE0103590D0 (sv)	2001-10-26

Legal Events

Date	Code	Title	Description
2009-05-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DK1509266T3 (da)	2009-10-19	System omfattende en dyse og et holdersystem
NO20044192L (no)	2004-10-04	17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
EP1412378A4 (en)	2006-09-20	APTAMERS AND ANTIAPTAMERS
DK1370128T3 (da)	2014-05-26	Kombineret ballepresse og ballevikler
DE60220542D1 (de)	2007-07-19	Fördereinrichtung
NO20031776L (no)	2003-10-20	Null-boringskomplettering og produksjonssystem
NO20015931D0 (no)	2001-12-04	Farmasöytiske formuleringer og fremgangsmåter som omfatter intranasal morfin
DK1450622T3 (da)	2013-04-02	Appetitvækkende faktor og smagsforstærker
IS7594A (is)	2004-12-13	Laxófoxifen tafla og húðun hennar
DK1322597T3 (da)	2012-07-02	Fremgangsmåde og intermediære
DE60045563D1 (de)	2011-03-03	Personenförderanlage
SG113471A1 (en)	2005-08-29	Chip-part conveying and holding apparatus
AU2003284110A8 (en)	2008-12-04	Jewelry and timepiece device
NO20023442D0 (no)	2002-07-17	N¶ringsmiddel og fremgangsmåte
IL165112A0 (en)	2005-12-18	Variant integrinpolypeptides and thereof
NO20033709D0 (no)	2003-08-20	Medisinske preparater omfattende Diklofenak og Ornoprostil
DK1565574T3 (da)	2010-06-21	Produkt og fremgangsmåde
NO20041649L (no)	2004-06-17	Et kombinasjonsprodukt omfattende melagatran og dexametason
FI20000876L (fi)	2001-10-13	Askelkuljetin
NO20032821D0 (no)	2003-06-19	Sea-trosy og beslektede fremgangsmåter
DE10195943T1 (de)	2003-08-07	Fördergerät
EP1499338A4 (en)	2008-06-18	7-HYDROXY-16ALPHA-FLUORO-5-ANDROSENES-17-ONE AND 7-HYDROXY-16ALPHA-FLUORO-5-ANDROSTAN-17-ONE AND THEIR DERIVATIVES
DE50201460D1 (de)	2004-12-09	Fördereinrichtung
DE60205000D1 (de)	2005-08-18	Fördervorrichtung
HK1066720A (en)	2005-04-01	A combination product comprising melagatran and dexamethasone